US Patent 10738305 Materials and methods for treatment of hemoglobinopathies
Patent 10738305 was granted and assigned to Vertex Pharmaceuticals on August, 2020 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
February 23, 2016
Date of Patent
August 11, 2020
Patent Applicant
Patent Application Number
15550943
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10738305 Materials and methods for treatment of hemoglobinopathies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
